text
"['\n2. 주요 제품 및 서비스\n가. 주요제품 매출\n(단위 : 백만원, %)\n사업부문\n매출유형\n품 \xa0 목\n구체적용도\n주요상표등\n제11기 반기\n제10기\n제9기\n매출액\n비율\n매출액\n비율\n매출액\n비율\n의약품 등\n제품\n그로트로핀\n성장호르몬\n-\n43,995\n13.91\n61,505\n9.68\n44,297\n\xa0 \xa0 7.47\n모티리톤\n기능성소화불량제\n-\n16,015\n5.06\n34,115\n5.37\n31,211\n\xa0 5.26\n슈가논\n당뇨병치료제\n-\n12,621\n3.99\n23,968\n3.77\n30,438\n\xa0 \xa05.13\n가스터\n소화성궤양치료제\n-\n10,534\n3.33\n23,438\n3.69\n23,693\n\xa0 \xa04.00\n주블리아\n손발톱무좀치료제\n-\n13,701\n4.33\n27,928\n4.40\n27,306\n\xa0 \xa04.60\n오팔몬\n허혈성개선제\n-\n12,573\n3.97\n24,628\n3.88\n23,377\n\xa0 3.94\n플라비톨\n항혈전제\n-\n9,475\n3.00\n22,226\n3.50\n21,786\n\xa0 3.67\n스티렌\n위점막보호제\n-\n9,655\n3.05\n20,404\n3.21\n19,535\n\xa0 3.29\n리피논\n고지혈증치료제\n-\n7,655\n2.42\n16,209\n2.55\n17,087\n\xa0 \xa02.88\n바라클\nB형간염치료제\n-\n3,831\n1.21\n7,559\n1.19\n7,316\n\xa0 \xa01.23\n상품\n캔박카스\n에너지드링크\n-\n37,425\n11.83\n93,922\n14.78\n80,763\n\xa013.61\n이달비\n고혈압치료제\n-\n5,750\n1.82\n11,217\n1.77\n10,351\n\xa0 1.74\n기타\n-\n-\n-\n133,090\n42.07\n268,273\n42.22\n256,068\n\xa043.18\n합계\n-\n-\n-\n-\n316,321\n100.00\n635,393\n100.00\n593,228\n\xa0100.00\n나. 주요제품 가격변동추이\n(단위 : 원)\n구 \xa0분\n제11기 반기\n제10기\n제9기\n전문의약품\n스티렌(1Tab)\n112\n112\n112\n리피논(20㎎. 1Tab)\n677\n677\n677\n플라비톨(1Tab)\n1,149\n1,149\n1,149\n모티리톤(1Tab)\n152\n152\n152\n슈가논(1Tab)\n730\n737\n737\n(1) 산출기준- 전문의약품 : 보험약가 기준(2) 주요 가격변동 원인- 전문의약품 : 선별등재시스템(PLS), 특허만료의약품 약가인하, 일괄약가인하, 사용량 약가연동제 등 정부의 약가인하 정책에 따른 가격통제를 받음\n']"
